UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX)
Phase 2
Recruiting
- Conditions
- Acute Ischemic Stroke
- Interventions
- Other: PlaceboBiological: Neuroncell-EX
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Cytopeutics Sdn. Bhd.
- Target Recruit Count
- 80
- Registration Number
- NCT06129175
- Locations
- 🇲🇾
Hospital Canselor Tuanku Muhriz UKM, Cheras, Wilayah Persekutuan Kuala Lumpur, Malaysia
Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury
Phase 2
Completed
- Conditions
- Osteoarthritis, Knee
- Interventions
- Procedure: Marrow cellutionBiological: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
- First Posted Date
- 2021-08-23
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Cytopeutics Sdn. Bhd.
- Target Recruit Count
- 28
- Registration Number
- NCT05016011
- Locations
- 🇲🇾
Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia (HCTM-UKM), Bandar Tun Razak, Wilayah Persekutuan Kuala Lumpur, Malaysia
UCMSCs as Front-line Approach of Treatment for Patients With aGVHD
Phase 1
Active, not recruiting
- Conditions
- Acute-graft-versus-host Disease
- Interventions
- Other: PlaceboBiological: Umbilical cord derived mesenchymal stem cell
- First Posted Date
- 2019-02-20
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Cytopeutics Sdn. Bhd.
- Target Recruit Count
- 26
- Registration Number
- NCT03847844
- Locations
- 🇲🇾
Hospital Ampang, Ampang, Selangor, Malaysia
© Copyright 2025. All Rights Reserved by MedPath